Table 6 Additional tests and costs with HC2 and Cobas versus Aptima over 2 years of follow-up, according to Portuguese geographic regions
From: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
Geographic Region | Additional tests, n = | Additional costs, € |
|---|---|---|
Continental Portugal—Norte region | ||
Hybrid Capture® 2 versus Aptima® HPV | 103,446 | 150,396,736.42 € |
Cobas® 4800 versus Aptima® HPV | 106,367 | 1,102,746.90 € |
Continental Portugal—Centro region | ||
Hybrid Capture® 2 versus Aptima® HPV | 56,718 | 82,461,472.06 € |
Cobas® 4800 versus Aptima® HPV | 58,320 | 604,628.36 € |
Continental Portugal—Lisbon region | ||
Hybrid Capture® 2 versus Aptima® HPV | 67,088 | 97,538,116.86 € |
Cobas® 4800 versus Aptima® HPV | 68,983 | 715,174.14 € |
Continental Portugal—Alentejo region | ||
Hybrid Capture® 2 versus Aptima® HPV | 14,535 | 21,131,433.38 € |
Cobas® 4800 versus Aptima® HPV | 14,945 | 154,941.01 € |
Continental Portugal—Algarve region | ||
Hybrid Capture® 2 versus Aptima® HPV | 10,698 | 15,553,100.72 € |
Cobas® 4800 versus Aptima® HPV | 11,000 | 114,039.27 € |
Autonomous region—Azores | ||
Hybrid Capture® 2 versus Aptima® HPV | 5450 | 7,923,513.82 € |
Cobas® 4800 versus Aptima® HPV | 5604 | 58,097.21 € |
Autonomous region—Madeira | ||
Hybrid Capture® 2 versus Aptima® HPV | 6025 | 8,759,864.81 € |
Cobas® 4800 versus Aptima® HPV | 6195 | 64,229.54 € |